Ocular alpha 2-receptor subclasses and antiglaucoma efficacy

J Ocul Pharmacol. 1994 Spring;10(1):359-69. doi: 10.1089/jop.1994.10.359.

Abstract

An overview of the ocular hypotensive actions of some alpha 2-agonists with imidazoline structures is presented. These agents inhibit isoproterenol-stimulated adenylate cyclase (AC) activity in ciliary process membrane through a Na+ and GTP-dependent mechanism. Receptor binding studies with the alpha 2-agonist radioligand [125I] p-iodoclonidine ([125I]PIC) in rabbit ciliary body membranes indicate that the alpha 2-receptor subtype is alpha 2A. Gpp(NH)p and NaCl dose-dependently decreased the number of [125I]PIC binding sites by shifting the receptor-G protein complexes from the high affinity state to the low affinity state for agonist binding. This is consistent with the observations that inhibition of AC was Na+ and GTP dependent. The NaCl and Gpp(NH)p effects on binding appeared to be through different mechanisms. The alpha 2-receptor in ciliary process thus appears to be an alpha 2A-receptor that is negatively coupled to the AC-cAMP generating system.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenylyl Cyclases / metabolism
  • Adrenergic alpha-Agonists / metabolism
  • Adrenergic alpha-Agonists / therapeutic use
  • Animals
  • Ciliary Body / drug effects
  • Ciliary Body / metabolism
  • Dose-Response Relationship, Drug
  • Female
  • Glaucoma / drug therapy*
  • Guanylyl Imidodiphosphate / pharmacology
  • Imidazoles / metabolism
  • Imidazoles / therapeutic use
  • Intraocular Pressure
  • Male
  • Rabbits
  • Receptors, Adrenergic, alpha-2 / classification*
  • Receptors, Adrenergic, alpha-2 / metabolism
  • Sodium Chloride / pharmacology

Substances

  • Adrenergic alpha-Agonists
  • Imidazoles
  • Receptors, Adrenergic, alpha-2
  • Guanylyl Imidodiphosphate
  • Sodium Chloride
  • Adenylyl Cyclases